Literature DB >> 17190445

Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora.

Min Chen1, Nicole Kilgore, Kuo-Hsiung Lee, Dao-Feng Chen.   

Abstract

Bioactivity-directed fractionation of an ethanolic extract of the fruits of Schisandra rubriflora led to the isolation and identification of dibenzocyclooctadiene lignans including the new lignans rubrisandrins A (1a + 1b) and B (2) and the known lignans gomisin J (3), (+/-)-gomisin M1 (4), (+)-gomisin M2 (5), schisanhenol (6), deoxyschisandrin, schisantherin B, schisandrin, tigloylgomisin P, gomisin O, angeloylgomisin P, and epigomisin O. Their structure and stereochemistry were determined by spectroscopic methods, including 2D-NMR techniques. Compounds 1 and 3-6 were active as anti-HIV agents. (+/-)-Gomisin M1 (4) exhibited the most potent anti-HIV activity, with EC50 and therapeutic index (TI) values of <0.65 microM and >68, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190445     DOI: 10.1021/np060239e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  15 in total

1.  From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors.

Authors:  Lijia Xu; Nicole Grandi; Claudia Del Vecchio; Daniela Mandas; Angela Corona; Dario Piano; Francesca Esposito; Cristina Parolin; Enzo Tramontano
Journal:  J Microbiol       Date:  2015-03-04       Impact factor: 3.422

2.  Extraction and Separation of Active Ingredients in Schisandra chinensis (Turcz.) Baill and the Study of their Antifungal Effects.

Authors:  Haijing Yi; Yan Chen; Jun Liu; Jie Zhang; Wei Guo; Weilie Xiao; Yuncong Yao
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

Review 3.  Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.

Authors:  Andreas Hensel; Rudolf Bauer; Michael Heinrich; Verena Spiegler; Oliver Kayser; Georg Hempel; Karin Kraft
Journal:  Planta Med       Date:  2020-05-20       Impact factor: 3.352

4.  Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium Levels.

Authors:  Hima Dhakal; Soyoung Lee; Eun-Nam Kim; Jin Kyeong Choi; Min-Jong Kim; Jinjoo Kang; Young-Ae Choi; Moon-Chang Baek; Byungheon Lee; Hyun-Shik Lee; Tae-Yong Shin; Gil-Saeng Jeong; Sang-Hyun Kim
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

Review 5.  The potential of plant systems to break the HIV-TB link.

Authors:  Peyman Habibi; Henry Daniell; Carlos Ricardo Soccol; Maria Fatima Grossi-de-Sa
Journal:  Plant Biotechnol J       Date:  2019-07-18       Impact factor: 9.803

Review 6.  Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products.

Authors:  Ramandeep Kaur; Pooja Sharma; Girish K Gupta; Fidele Ntie-Kang; Dinesh Kumar
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

Review 7.  Plant-derived lignans as potential antiviral agents: a systematic review.

Authors:  Xin-Ya Xu; Dong-Ying Wang; Yi-Ping Li; Stephen T Deyrup; Hong-Jie Zhang
Journal:  Phytochem Rev       Date:  2021-05-31       Impact factor: 7.741

8.  Neglschisandrins C-D: two new dibenzocyclooctadiene lignans from Schisandra neglecta.

Authors:  Min Chen; Zhihua Liao; Xiumei Xu; Yan Wen; Min Sun; Haoxiang Zhang; Wenhui Ma
Journal:  Molecules       Date:  2008-05-13       Impact factor: 4.411

9.  Neglschisandrins E-F: two new lignans and related cytotoxic lignans from Schisandra neglecta.

Authors:  Min Chen; Xiumei Xu; Bing Xu; Panpan Yang; Zhihua Liao; Susan L Morris-Natschke; Kuo-Hsiung Lee; Daofeng Chen
Journal:  Molecules       Date:  2013-02-19       Impact factor: 4.411

10.  Neglschisandrins A-B: two new dibenzocyclooctene lignans from Schisandra neglecta.

Authors:  Min Chen; Xiumei Xu; Zhihua Liao; Li Dong; Lei Li; Chengzhi Huang
Journal:  Molecules       Date:  2008-03-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.